Viewing Study NCT00016068


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2025-12-28 @ 5:25 PM
Study NCT ID: NCT00016068
Status: COMPLETED
Last Update Posted: 2010-05-17
First Post: 2001-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
Sponsor: Fred Hutchinson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 1577.00
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View